Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
43.17
+0.74 (1.74%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Exact Sciences Revenue

Exact Sciences had revenue of $2.53B in the twelve months ending March 31, 2024, with 15.21% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $637.52M with 5.82% year-over-year growth. In the year 2023, Exact Sciences had annual revenue of $2.50B with 19.93% growth.

Revenue (ttm)
$2.53B
Revenue Growth
+15.21%
P/S Ratio
3.14
Revenue / Employee
$384,067
Employees
6,600
Market Cap
7.97B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.50B415.49M19.93%
Dec 31, 20222.08B317.19M17.95%
Dec 31, 20211.77B275.70M18.49%
Dec 31, 20201.49B615.10M70.19%
Dec 31, 2019876.29M421.83M92.82%
Dec 31, 2018454.46M188.47M70.86%
Dec 31, 2017265.99M166.61M167.66%
Dec 31, 201699.38M59.94M151.99%
Dec 31, 201539.44M37.64M2,093.38%
Dec 31, 20141.80M-2.35M-56.61%
Dec 31, 20134.14M--
Dec 31, 20124.14M-19.00K-0.46%
Dec 31, 20114.16M-1.18M-22.10%
Dec 31, 20105.34M586.00K12.32%
Dec 31, 20094.76M5.63M-648.79%
Dec 31, 2008-867.00K-2.67M-148.22%
Dec 31, 20071.80M-2.95M-62.15%
Dec 31, 20064.75M500.00K11.76%
Dec 31, 20054.25M-685.00K-13.88%
Dec 31, 20044.94M2.03M70.11%
Dec 31, 20032.90M2.00M223.41%
Dec 31, 2002897.00K846.00K1,658.82%
Dec 31, 200151.00K--
Dec 31, 20000--
Dec 31, 19990--
Dec 31, 19980--
Dec 31, 19970--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Henry Schein 12.45B
Elanco Animal Health 4.37B
Bio-Rad Laboratories 2.61B
HealthEquity 1.04B
Intra-Cellular Therapies 513.93M
Ascendis Pharma 357.63M
Legend Biotech 342.80M
Roivant Sciences 124.80M
Revenue Rankings